Boston Scientific Corporation (BSX) Business Update Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Business Update Earnings Conference Call October 30, 2024 4:00 PM ET

Company Participants

Jonathan Monson - Senior Vice President of Investor Relations
Joseph Fitzgerald - Executive Vice President and Group President, Cardiology
Lance Bates - Senior Vice President and President
Janar Sathananthan - Chief Medical Officer
Kenneth Stein - Chief Medical Officer

Conference Call Participants

Operator

Good day, and welcome to the Boston Scientific Cardiology Business Update. [Operator Instructions]

Please note, this event is being recorded. I would like now to turn the program over to Jon Monson, Senior Vice President of Investor Relations. Please go ahead.

Jonathan Monson

Thank you, Alan, and welcome, everyone, on the webcast. We have our Cardiology leadership team here today, including Joe Fitzgerald, Executive Vice President and Group President, Cardiology; Lance Bates, Senior Vice President and President, ICTx; Dr. Janar Sathananthan, Chief Medical Officer, ICTx; and Dr. Ken Stein, our Chief Medical Officer, who will join for the Q&A. Before we begin, we have a few housekeeping items.

The duration of today's call will be approximately one hour. Q&A will follow our presentation, and we'll take questions through the webcast.

We'll be making forward-looking statements. So you can see here our typical safe harbor and risk factors apply. You can see here our regulatory disclaimers and our financial disclaimers as well.

So at this point, I'll turn the call over to Joe. Joe?

Joseph Fitzgerald

Thanks, Jon. Appreciate it, and thanks, everyone, for joining us.

Just an update on our Cardiology served markets. Today, we call this nearly a $40 billion market of things that are happening in the cath lab, growing in our projection at about an 8% CAGR through the end of '27.

What I particularly like about this is if I compare this to maybe five or